Tilia Fiduciary Partners’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.69M Buy
7,801
+104
+1% +$52.4K 2.03% 12
2025
Q4
$3.59M Buy
7,697
+74
+1% +$34.4K 1.98% 11
2025
Q3
$3.25M Sell
7,623
-209
-3% -$81K 1.88% 11
2025
Q2
$3M Buy
7,832
+88
+1% +$31.7K 1.83% 12
2025
Q1
$2.68M Buy
7,744
+214
+3% +$68.8K 1.78% 13
2024
Q4
$2.26M Buy
7,530
+265
+4% +$92.6K 1.54% 25
2024
Q3
$2.95M Buy
7,265
+150
+2% +$54.9K 2.05% 11
2024
Q2
$2.29M Buy
7,115
+395
+6% +$128K 1.79% 16
2024
Q1
$2.24M Buy
6,720
+370
+6% +$113K 1.82% 16
2023
Q4
$1.72M Buy
6,350
+413
+7% +$102K 1.6% 23
2023
Q3
$1.46M Buy
5,937
+264
+5% +$72.2K 1.52% 26
2023
Q2
$1.72M Buy
5,673
+28
+0.5% +$7.78K 1.54% 15
2023
Q1
$1.49M Buy
5,645
+20
+0.4% +$5.08K 1.42% 14
2022
Q4
$1.35M Buy
5,625
+60
+1% +$13.4K 1.3% 19
2022
Q3
$1.13M Buy
5,565
+145
+3% +$28.9K 1.14% 24
2022
Q2
$922K Buy
5,420
+322
+6% +$69.2K 0.88% 37
2022
Q1
$1.28M Buy
5,098
+146
+3% +$36.7K 1.08% 22
2021
Q4
$1.27M Buy
+4,952
New +$1.21M 1.02% 29

Other funds holding HCA

Tilia Fiduciary Partners's HCA Position: Q1 2026 in Review

Tilia Fiduciary Partners increased its HCA Healthcare (HCA) stake by 1.4% in Q1 2026, buying an estimated $52.4K and bringing the position to 7,801 shares worth $3.69M. The position accounts for 2.03% of the portfolio, ranked #12.

Tilia Fiduciary Partners first reported a position in HCA in Q4 2021 and has held it in 18 quarters since. 1,415 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Tilia Fiduciary Partners held 7,801 shares of HCA Healthcare worth $3.69M as of Q1 2026.
  • Tilia Fiduciary Partners bought 104 HCA Healthcare shares in Q1 2026, an estimated $52.4K.
  • HCA Healthcare made up 2.03% of Tilia Fiduciary Partners's portfolio in Q1 2026, its #12 holding.
  • Tilia Fiduciary Partners first reported a position in HCA Healthcare in Q4 2021 and has held it in 18 quarters since.
  • 1,415 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Tilia Fiduciary Partners's 13F filing for Q1 2026, filed 9 Apr 2026.